Activation of PyMT in β Cells Induces Irreversible Hyperplasia, but Oncogene-Dependent Acinar Cell Carcinomas When Activated in Pancreatic Progenitors
Yi-Chieh Nancy Du, David S. Klimstra, Harold Varmus · 2009
Read Activation of PyMT in β Cells Induces Irreversible Hyperplasia, but Oncogene-Dependent Acinar Cell Carcinomas When Activated in Pancreatic Progenitors by Yi-Chieh Nancy Du, David S. Klimstra, Harold Varmus (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006932.txt.
Description
Yi-Chieh Nancy Du, David Klimstra, and Harold Varmus used engineered mice to study pancreatic cancer in PLOS ONE in 2009. A basic question was unsettled at the time. Do different pancreatic tumors start from different target cells, or from shared precursors? The team switched on an oncogene called PyMT in chosen cell types.
In insulin-producing beta cells, PyMT caused irreversible overgrowth called hyperplasia. In pancreatic progenitor cells, it produced acinar cell carcinomas that depended on the oncogene. The contrast shows that the starting cell shapes the tumor that follows. That insight guides how researchers model and classify pancreatic cancers.
Catalog record
| CREATOR | Yi-Chieh Nancy Du, David S. Klimstra, Harold Varmus |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006932